Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON42399
NL-OMON42399
Recruiting
Not Applicable

Bubbling therapy for dysfunctional breathing in difficult to treat asthma - a pilot study - Bubble study

Sint Franciscus Gasthuis0 sites78 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsasthmadysfunctional breathing10006436

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
asthma
Sponsor
Sint Franciscus Gasthuis
Enrollment
78
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Difficult to treat asthma
  • •And either/or
  • •o Chronic hypocapnia (pCO2 \< 4\.7 kPa and HCO3\- \< 23 mEq/L)
  • •o Clinical signs of vocal cord dysfunction with PVCDI \> 4
  • •No anatomical or mechanical abnormalities in the naso\-oro\-hypo\-pharyngeal tract

Exclusion Criteria

  • •Current smoking or more than 10 PY in history
  • •Recent exacerbation of asthma or airway infection (\< 6 weeks)
  • •Anatomical abnormalities of the upper/lower airway tract
  • •Inability to perform a reproducible lung function test
  • •Another untreated causative factor for uncontrolled asthma
  • •FEV1 post\-bronchodilator \< 80% of predicted.
  • •FeNO \> 50 ppb

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
ovel diagnostics in dysfunctional breathing using a wearable breathing trainerAdemhalingsstelsel, adempatroonafwijkingenbreathing pattern disorderineffective breathing
NL-OMON56859Medisch Spectrum Twente25
Not yet recruiting
Not Applicable
se of Bubble Breathe Technique in managing gagging while making dental impressions in children.
CTRI/2022/01/039381vaishaki kamath
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.Refractory breathlessness in patients diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).MedDRA version: 21.1Level: LLTClassification code 10009032Term: Chronic obstructive lung diseaseSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2019-002001-21-ITniversity College Dublin324
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.Refractory breathlessness in patients diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2019-002001-21-GBKing's College London324
Active, not recruiting
Phase 1
BETTER-B: Better Treatments for Refractory Breathlessness.
EUCTR2019-002001-21-IEniversity College Dublin324